Technical Analysis for NFX - Nuformix Plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Historical NFX trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | -2.17% | |
Wide Bands | Range Expansion | -2.17% | |
Oversold Stochastic | Weakness | -2.17% | |
Hammer Candlestick | Bullish | -4.26% | |
Narrow Range Bar | Range Contraction | -4.26% | |
Doji - Bullish? | Reversal | -4.26% | |
Outside Day | Range Expansion | -4.26% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
1.5x Volume Pace | 1 day ago |
Fell Below Previous Day's Low | 1 day ago |
Down 3% | 1 day ago |
Down 2% | 1 day ago |
Down 1% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Nuformix PLC, formerly Levrett PLC, is a United Kingdom-based pharmaceutical development company. The Company uses cocrystal technology to develop drugs with programs in oncology supportive care and fibrosis. It uses cocrystal technology to re-engineer the crystalline form of drugs. Its clinical pipeline includes NXP001 and NXP002. Its pre-clinical pipeline includes NXP003. It is developing NXP001 for oncology supportive care. It is developing NXP002 for the treatment of multiple fibrotic diseases. NXP003 targets a mechanism understood to confer resistance to immuno-oncology, chemotherapy and radiotherapy cancer treatments.
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Support Target Pharmaceutical Medicine Clinic Pipe Disease Radio Cancer Diseases Oncology Drugs Therapy Vr Resistance Crystallography Radiotherapy Chemotherapy Fibrosis Cancer Treatments Pharmaceutical Development Radiation Therapy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Support Target Pharmaceutical Medicine Clinic Pipe Disease Radio Cancer Diseases Oncology Drugs Therapy Vr Resistance Crystallography Radiotherapy Chemotherapy Fibrosis Cancer Treatments Pharmaceutical Development Radiation Therapy
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Date | Title |
---|
Indicator | Value |
---|---|
52 Week High | 6.9 |
52 Week Low | 1.8255 |
Average Volume | 5,887,135 |
200-Day Moving Average | 3.08 |
50-Day Moving Average | 2.53 |
20-Day Moving Average | 2.45 |
10-Day Moving Average | 2.39 |
Average True Range | 0.26 |
ADX | 17.94 |
+DI | 23.07 |
-DI | 18.60 |
Chandelier Exit (Long, 3 ATRs ) | 2.86 |
Chandelier Exit (Short, 3 ATRs ) | 2.87 |
Upper Bollinger Band | 2.94 |
Lower Bollinger Band | 1.97 |
Percent B (%b) | 0.29 |
BandWidth | 39.40 |
MACD Line | -0.06 |
MACD Signal Line | -0.05 |
MACD Histogram | -0.008 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.39 | ||||
Resistance 3 (R3) | 2.38 | 2.34 | 2.36 | ||
Resistance 2 (R2) | 2.34 | 2.30 | 2.34 | 2.35 | |
Resistance 1 (R1) | 2.29 | 2.28 | 2.32 | 2.30 | 2.35 |
Pivot Point | 2.25 | 2.25 | 2.26 | 2.25 | 2.25 |
Support 1 (S1) | 2.20 | 2.21 | 2.23 | 2.21 | 2.15 |
Support 2 (S2) | 2.16 | 2.19 | 2.16 | 2.15 | |
Support 3 (S3) | 2.11 | 2.16 | 2.14 | ||
Support 4 (S4) | 2.12 |